ICON reports 10% increase in net revenues and EPS of 45 cents Read more about ICON reports 10% increase in net revenues and EPS of 45 cents
ICON reports 10% increase in net revenues and EPS of 42 cents Read more about ICON reports 10% increase in net revenues and EPS of 42 cents
ICON Clinical Research named a “top CRO” in 2005 CenterWatch Site Survey Read more about ICON Clinical Research named a “top CRO” in 2005 CenterWatch Site Survey
ICON named “Top CRO” for quality and execution in pharma industry survey Read more about ICON named “Top CRO” for quality and execution in pharma industry survey
Bill Taaffe transitions into new role after 12 years as president and CEO for ICON Clinical Research-US Read more about Bill Taaffe transitions into new role after 12 years as president and CEO for ICON Clinical Research-US
ICON Clinical Research Signs Technology Licensing Agreement with Medidata Solutions Read more about ICON Clinical Research Signs Technology Licensing Agreement with Medidata Solutions
ICON Clinical Research establishes office in Chennai, India Read more about ICON Clinical Research establishes office in Chennai, India
ICON reports a 9% increase in net revenues, EPS of $0.41 and net new business awards of $120 million for the Second Quarter FY 2005 (NASDAQ:ICLR) Read more about ICON reports a 9% increase in net revenues, EPS of $0.41 and net new business awards of $120 million for the Second Quarter FY 2005 (NASDAQ:ICLR)
